BJERKHOLT ERIC — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BJERKHOLT ERIC has filed 6 SEC Form 4 filings across 4 companies in the last 90 days — selling. Lifetime open-market sales: $2.80M.

Profile

BJERKHOLT ERIC

Eric Bjerkholt is a corporate executive known for his role as Chief Financial Officer at Mirum Pharmaceuticals, Inc. He has also held similar positions at other biopharmaceutical companies, contributing to the financial management and strategic direction of these organizations.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-08MIRMMirum Pharmaceuticals, Inc.S — Open-market sale300$124.94$37K
2026-07-08MIRMMirum Pharmaceuticals, Inc.S — Open-market sale528$123.84$65K
2026-07-08MIRMMirum Pharmaceuticals, Inc.S — Open-market sale1.0K$122.43$128K
2026-07-08MIRMMirum Pharmaceuticals, Inc.S — Open-market sale3.1K$121.67$380K
2026-06-12CERSCERUS CORPS — Open-market sale20.5K$2.60$53K
2026-06-10MIRMMirum Pharmaceuticals, Inc.M — Option exercise2.4K$26.49$63K
2026-06-10MIRMMirum Pharmaceuticals, Inc.S — Open-market sale1.6K$95.12$149K
2026-06-10MIRMMirum Pharmaceuticals, Inc.S — Open-market sale1.2K$93.95$110K
2026-06-10MIRMMirum Pharmaceuticals, Inc.S — Open-market sale2.3K$92.84$210K
2026-06-02CERSCERUS CORPA — Grant or award60.0K$0.00
2026-03-17MIRMMirum Pharmaceuticals, Inc.S — Open-market sale7.3K$91.98$670K
2026-03-17MIRMMirum Pharmaceuticals, Inc.M — Option exercise13.3K—
2026-01-27MIRMMirum Pharmaceuticals, Inc.S — Open-market sale1.1K$96.19$101K
2026-01-27MIRMMirum Pharmaceuticals, Inc.M — Option exercise2.7K—
2026-01-23MIRMMirum Pharmaceuticals, Inc.S — Open-market sale1.4K$93.33$133K
2026-01-23MIRMMirum Pharmaceuticals, Inc.M — Option exercise3.3K—
2025-09-11MIRMMirum Pharmaceuticals, Inc.S — Open-market sale9.6K$76.01$728K
2025-09-11MIRMMirum Pharmaceuticals, Inc.M — Option exercise18.3K—
2025-08-11MIRMMirum Pharmaceuticals, Inc.M — Option exercise3.0K$26.49$78K
2025-08-11MIRMMirum Pharmaceuticals, Inc.S — Open-market sale8.0K—

Companies — Last 90 Days

Frequently Asked Questions

Who is BJERKHOLT ERIC?

Eric Bjerkholt is a corporate executive known for his role as Chief Financial Officer at Mirum Pharmaceuticals, Inc. He has also held similar positions at other biopharmaceutical companies, contributing to the financial management and strategic direction of these organizations.…

How many SEC Form 4 filings has BJERKHOLT ERIC submitted recently?

6 primary Form 4 filings in the last 90 days, covering 4 companies.

Has BJERKHOLT ERIC been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 14 open-market sales ($2.80M) across all tracked filings.

Where can I see all of BJERKHOLT ERIC's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live BJERKHOLT ERIC profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.